FindTrial
Sign In

Quality of Tumor Immunotherapy Information on Internet Videos Commonly Used by Chinese Population

Quality of Tumor Immunotherapy Information on Internet Videos Commonly Used by Chinese Population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081071
Enrollment
Unknown
Registered
2024-02-21
Start date
2024-02-26
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Videos related to tumor immunotherapy:non

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Using the keyword "tumor immunotherapy" in Chinese, we searched TikTok, Tencent, iQiyi and Bilibili, respectively. The videos were sorted according to video's default "the most viewed" sorting and the first 50 videos per website were evaluated.

Exclusion criteria

Exclusion criteria: Duplicate videos, paid videos and videos clearly not related to tumor immunotherapy were excluded.

Design outcomes

Primary

MeasureTime frame
quality of videos;—

Secondary

MeasureTime frame
content of videos;—

Countries

China

Contacts

Public ContactChenxu Ni

Shanghai Tenth People's Hospital

nichenxu@126.com+86 135 2450 6143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026